Ibogaine, LSD and Psilocybin: Trump's New Order a Medical ...
Military veterans may eventually see newer forms of mental health relief by way of treatments being greenlighted by the president himself.
www.military.comHere’s the latest on ibogaine based on available reporting up to now.
-
Texas has been a focal point for ibogaine news, with coverage of state-funded clinical trial initiatives and advocacy for FDA-approved trials. Reports in 2025 highlighted a $50 million state initiative to support ibogaine trials and public-private partnerships, positioning Texas as a leader in psychedelic research funding. [Sources discuss: Texas funding and legislative steps toward ibogaine trials; advocacy by figures like Rick Perry and veterans groups.]
-
There has been ongoing discussion about U.S. regulatory status and cross-border access, as ibogaine remains illegal at the federal level in the U.S., while clinics in Mexico and other countries offer treatment options. Media coverage in 2025–2026 has explored the mismatch between potential therapeutic interest and legal constraints, including notable cases and policy debates.
-
Related research and commentary continue to surface on potential neurobiological effects and clinical prospects, including studies and expert opinions about ibogaine’s safety, efficacy, and mechanism, as well as broader discussions about psychedelic-assisted therapies for addiction, PTSD, and traumatic brain injury.
-
Public and media interest remains high due to patient anecdotes, veteran advocacy, and policy moves aiming to fund trials that could lead to FDA approval, though no FDA-approved ibogaine treatment exists in the United States as of now.
-
A notable development is ongoing coverage of how ibogaine is being positioned within broader U.S. psychedelic policy shifts, including potential regulatory and clinical pathways that could change its availability if trials show favorable risk-benefit profiles.
If you’d like, I can:
- Summarize the key legal and funding milestones in Texas with dates.
- Pull the most recent official statements from Texas lawmakers or medical organizations.
- Create a quick timeline or an at-a-glance briefing with the main players, funding amounts, and expected FDA timelines.